Literature DB >> 11805308

Six blind men and the elephant--the many faces of heparan sulfate.

Ajit Varki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11805308      PMCID： PMC117338          DOI： 10.1073/pnas.022649499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

Review 1.  Heparanase: a key enzyme involved in cell invasion.

Authors:  C R Parish; C Freeman; M D Hulett
Journal:  Biochim Biophys Acta       Date:  2001-03-21

Review 2.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 4.  Heparin.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

5.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 6.  Heparin and cancer.

Authors:  L R Zacharski; D L Ornstein
Journal:  Thromb Haemost       Date:  1998-07       Impact factor: 5.249

7.  Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Authors:  L Borsig; R Wong; J Feramisco; D R Nadeau; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 8.  Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.

Authors:  Nissi M Varki; Ajit Varki
Journal:  Semin Thromb Hemost       Date:  2002-02       Impact factor: 4.180

9.  Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

Authors:  Z Shriver; M Sundaram; G Venkataraman; J Fareed; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

10.  Heparin structure and interactions with basic fibroblast growth factor.

Authors:  S Faham; R E Hileman; J R Fromm; R J Linhardt; D C Rees
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728
View more
  3 in total

1.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

Review 2.  Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseases.

Authors:  Steven B Oppenheimer; Maribel Alvarez; Jennifer Nnoli
Journal:  Acta Histochem       Date:  2007-10-25       Impact factor: 2.479

3.  Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.

Authors:  Nirmita J Patel; Chetna Sharon; Somesh Baranwal; Rio S Boothello; Umesh R Desai; Bhaumik B Patel
Journal:  Oncotarget       Date:  2016-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.